Literature DB >> 5762490

Adenovirus susceptibility to interferon: sensitivity of types 2,7, and 12 to human interferon.

J G Gallagher, N Khoobyarian.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5762490     DOI: 10.3181/00379727-130-33506

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  8 in total

1.  Topical human fibroblast interferon for acute adenoviral conjunctivitis.

Authors:  K R Wilhelmus; E C Dunkel; J Herson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

Review 2.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1970-05       Impact factor: 2.401

3.  Relative sensitivities of viruses to different species of interferon.

Authors:  W E Stewart; W D Scott; S E Sulkin
Journal:  J Virol       Date:  1969-08       Impact factor: 5.103

4.  Adenovirus susceptibility to human interferon during one-step replication.

Authors:  J G Gallagher; N Khoobyarian
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

5.  Paracrystal formation in cell cultures infected with adenovirus type 2.

Authors:  C J Henry; R W Atchison
Journal:  J Virol       Date:  1971-12       Impact factor: 5.103

6.  Control of simian virus 40 gene expression in adenovirus-simian virus 40 hybrid viruses. Synthesis of hybrid adenovirus 2-simian virus 40 RNA molecules in cells infected with a nondefective adenovirus 2-simian virus 40 hybrid virus.

Authors:  M N Oxman; M J Levin; A M Lewis
Journal:  J Virol       Date:  1974-02       Impact factor: 5.103

Review 7.  Adenoviruses in the immunocompromised host.

Authors:  J C Hierholzer
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

Review 8.  Antiviral chemotherapy and prophylaxis of viral respiratory disease.

Authors:  S J Sperber; F G Hayden
Journal:  Clin Lab Med       Date:  1987-12       Impact factor: 1.935

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.